Nod for Atezolizumab in Advanced Bladder Cancer [News in Brief]

The FDA approved atezolizumab to treat advanced bladder cancer when cisplatin chemotherapy is contraindicated. The approval offers a potentially more effective alternative to carboplatin-based chemotherapy for frail, elderly patients.
Source: Cancer Discovery - Category: Cancer & Oncology Tags: News in Brief Source Type: research